| 发明名称 |
PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS |
| 摘要 |
The invention relates to pharmaceutical oral dosage forms of the active substance ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H- benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate (dabigatran etexilate) and the pharmacologically acceptable salts thereof, in particular dabigatran etexilate methanesulfonate. |
| 申请公布号 |
WO2012001156(A3) |
申请公布日期 |
2012.08.30 |
| 申请号 |
WO2011EP61140 |
申请日期 |
2011.07.01 |
| 申请人 |
KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO;KROSELJ, VESNA |
发明人 |
KROSELJ, VESNA |
| 分类号 |
A61K9/50;A61K31/4439 |
主分类号 |
A61K9/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
